Clinic
ST. Luke's Hospital Grand View Campus
ST. Luke's Hospital Grand View Campus was paid $2.45M by Medicaid between Nov 2019 and Nov 2024, across 64 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoST. LUKE'S HOSPITAL GRAND VIEW CAMPUS
SELLERSVILLE, PA 18960
SELLERSVILLE, PA 18960
33aNPI1568459287assigned 09/29/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$2.45M
24GClaims26,916
24DCodes billed64
24AFirst – last monthNov 2019 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Pennsylvania
Rank by total paid#9 of 119
Median peer was paid$57K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WOLFE, SCOTT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 43 | $2K | |
| 2020 | 6,321 | $298K | |
| 2021 | 14,053 | $1.20M | |
| 2022 | 2,998 | $545K | |
| 2023 | 2,059 | $293K | |
| 2024incomplete | 1,442 | $112K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 4,629 | 4,464 | $807K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 3,605 | 3,459 | $638K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 1,696 | 1,605 | $449K |
| G0378 | Hospital observation service, per hour | 9.7% | 261 | 217 | $236K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.8% | 469 | 461 | $44K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 2,184 | 588 | $38K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.3% | 1,128 | 338 | $32K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 297 | 217 | $18K |
| 76830 | Ultrasound, transvaginal | <1% | 307 | 302 | $16K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 179 | 178 | $16K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 53 | 25 | $12K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 345 | 339 | $12K |
52 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 556 | $12K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 465 | $11K |
| 97010 | <1% | 828 | $10K | |
| 0002A | <1% | 148 | $7K | |
| 97161 | <1% | 96 | $6K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 55 | $5K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 38 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 401 | $5K |
| 76642 | <1% | 106 | $5K | |
| 0001A | <1% | 155 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 173 | $4K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 13 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 124 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 156 | $4K |
| 59025 | Fetal non-stress test | <1% | 574 | $3K |
| 76801 | <1% | 73 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,070 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 666 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 264 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 535 | $2K |
| 76536 | <1% | 39 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 33 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 76 | $2K |
| 0031A | <1% | 40 | $2K | |
| 71250 | <1% | 24 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 238 | $2K |
| 77080 | <1% | 26 | $2K | |
| 76775 | <1% | 27 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,704 | $956.58 |
| 73630 | <1% | 56 | $695.88 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 236 | $675.37 |
| 71045 | Radiologic examination, chest; single view | <1% | 172 | $620.83 |
| 81000 | <1% | 295 | $552.06 | |
| 73030 | <1% | 32 | $473.70 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 42 | $342.57 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $336.41 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 17 | $312.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 13 | $263.87 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 32 | $252.13 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,285 | $222.45 |
| 73610 | <1% | 12 | $178.76 | |
| 85730 | <1% | 103 | $163.52 | |
| 85610 | <1% | 124 | $162.04 | |
| 87088 | <1% | 33 | $144.80 | |
| 82947 | <1% | 95 | $133.58 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 74 | $90.14 |
| 84484 | <1% | 33 | $78.96 | |
| 81025 | <1% | 36 | $20.60 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 15 | $0.10 |
| J3490 | Unclassified drugs | 0% | 33 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 262 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 48 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWOLFE, SCOTT (SENIOR VP FINANCE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.